Outbreaks are due to lack of natural immunity, abrupt lifting of curbs…
From Tuesday onwards, Mock drills will be conducted at hospitals across the country in view of a spike in Covid cases in some countries, the union health ministry said on Friday, 23 December 2022, adding that it is preparing fresh guidelines for Christmas and New Year too.
"The pandemic is not over yet. During the festive season, it is imperative to create awareness for adherence to Covid-appropriate behaviour," the health ministry said.
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said today.
Those who have taken Covishield and Covaxin can take the nasal vaccine in the form of booster dose.
The needle-free vaccine will be available at private centres from now. It will be introduced on the Co-WIN platform on Friday evening, sources said.
The nasal vaccine that is BBV154 or iNCOVACC received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a booster dose.
"There has been a trend that Covid-19 starts spreading from China, Korea, Brazil, and then comes to South Asia. It has reached India in 20–35 days.
The Brief. Sign up to receive the top stories you need to know right now.